141 related articles for article (PubMed ID: 34171599)
1. MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancer.
Rico SD; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; von Leffern I; Heilenkötter U; Jacobsen F; Bernreuther C; Clauditz T; Simon R; Steurer S; Burandt E; Marx AH; Krech T
Pathol Res Pract; 2021 Aug; 224():153533. PubMed ID: 34171599
[TBL] [Abstract][Full Text] [Related]
2. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas.
Ji H; Isacson C; Seidman JD; Kurman RJ; Ronnett BM
Int J Gynecol Pathol; 2002 Oct; 21(4):391-400. PubMed ID: 12352188
[TBL] [Abstract][Full Text] [Related]
4. Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer.
Rico SD; Höflmayer D; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Möller-Koop C; Perez D; Izbicki JR; Neipp M; Mofid H; Lárusson H; Daniels T; Isbert C; Coerper S; Ditterich D; Rupprecht H; Goetz A; Fraune C; Möller K; Menz A; Bernreuther C; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Lebok P; Burandt E; Krech T; Marx AH
Med Mol Morphol; 2021 Jun; 54(2):156-165. PubMed ID: 33373033
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma.
Albarracin CT; Jafri J; Montag AG; Hart J; Kuan SF
Hum Pathol; 2000 Jun; 31(6):672-7. PubMed ID: 10872659
[TBL] [Abstract][Full Text] [Related]
6. Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas.
Losi L; Scarselli A; Benatti P; Ponz de Leon M; Roncucci L; Pedroni M; Borghi F; Lamberti I; Rossi G; Marino M; Ponti G; Zangardi G; Menigatti M; Di Gregorio C
Pathol Res Pract; 2004; 200(5):371-7. PubMed ID: 15239345
[TBL] [Abstract][Full Text] [Related]
7. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.
Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M
Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366
[TBL] [Abstract][Full Text] [Related]
8. Analysis of blood group antigens on MUC5AC in mucinous ovarian cancer tissues using in situ proximity ligation assay.
Mateoiu C; Vitiazeva V; Kristjansdottir B; Weijdegård B; Örnros J; Gallini R; Kamali-Moghaddam M; Sundfeldt K; Karlsson NG
Glycobiology; 2021 Dec; 31(11):1464-1471. PubMed ID: 34459484
[TBL] [Abstract][Full Text] [Related]
9. Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.
Dwertmann Rico S; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Perez D; Izbicki JR; Neipp M; Mofid H; Daniels T; Isbert C; Fraune C; Möller K; Menz A; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Burandt E; Marx A; Krech T
Int J Immunopathol Pharmacol; 2022; 36():3946320221106504. PubMed ID: 35764407
[No Abstract] [Full Text] [Related]
10. Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.
Wang J; El-Bahrawy M
Histopathology; 2015 Mar; 66(4):529-35. PubMed ID: 25298197
[TBL] [Abstract][Full Text] [Related]
11. MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10 399 Tissue Samples.
Rico SD; Mahnken M; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Möller-Koop C; Fraune C; Möller K; Menz A; Bernreuther C; Jacobsen F; Lebok P; Clauditz TS; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Minner S; Burandt E; Krech T; Marx AH
Technol Cancer Res Treat; 2021; 20():15330338211043328. PubMed ID: 34547930
[No Abstract] [Full Text] [Related]
12. A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary.
Chelariu-Raicu A; Holley E; Mayr D; Klauschen F; Wehweck F; Rottmann M; Kessler M; Kaltofen T; Czogalla B; Trillsch F; Mahner S; Schmoeckel E
Int J Gynecol Cancer; 2022 May; 32(5):662-668. PubMed ID: 35185017
[TBL] [Abstract][Full Text] [Related]
13. The O-Linked Glycome and Blood Group Antigens ABO on Mucin-Type Glycoproteins in Mucinous and Serous Epithelial Ovarian Tumors.
Vitiazeva V; Kattla JJ; Flowers SA; Lindén SK; Premaratne P; Weijdegård B; Sundfeldt K; Karlsson NG
PLoS One; 2015; 10(6):e0130197. PubMed ID: 26075384
[TBL] [Abstract][Full Text] [Related]
14. High homogeneity of MMR deficiency in ovarian cancer.
Fraune C; Rosebrock J; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Höflmayer D; Schmalfeldt B; Müller V; Wölber L; Witzel I; Paluchowski P; Wilke C; Heilenkötter U; von Leffern I; Clauditz TS; Wilczak W; Sauter G; Steurer S; Burandt E
Gynecol Oncol; 2020 Mar; 156(3):669-675. PubMed ID: 31924330
[TBL] [Abstract][Full Text] [Related]
15. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
[TBL] [Abstract][Full Text] [Related]
17. Tomm34 is commonly expressed in epithelial ovarian cancer and associates with tumour type and high FIGO stage.
Muller P; Coates PJ; Nenutil R; Trcka F; Hrstka R; Chovanec J; Brychtova V; Vojtesek B
J Ovarian Res; 2019 Mar; 12(1):30. PubMed ID: 30917858
[TBL] [Abstract][Full Text] [Related]
18. Expression profile of mucins in ovarian mucinous tumors: distinguishing primary ovarian from metastatic tumors.
Wang J; El-Bahrawy MA
Int J Gynecol Pathol; 2014 Mar; 33(2):166-75. PubMed ID: 24487472
[TBL] [Abstract][Full Text] [Related]
19. AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation.
Armes JE; Davies CM; Wallace S; Taheri T; Perrin LC; Autelitano DJ
Pathology; 2013 Jan; 45(1):49-54. PubMed ID: 23222243
[TBL] [Abstract][Full Text] [Related]
20. Mucin core protein expression by colorectal mucinous carcinomas with or without mucus hyperplasia.
Ishizu H; Kumagai J; Eishi Y; Takizawa T; Koike M
J Gastroenterol; 2004; 39(2):125-32. PubMed ID: 15069618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
